CIBC Asset Management Inc Grows Position in Encompass Health Co. (NYSE:EHC)

CIBC Asset Management Inc lifted its position in shares of Encompass Health Co. (NYSE:EHC) by 3.5% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,957 shares of the company’s stock after purchasing an additional 100 shares during the quarter. CIBC Asset Management Inc’s holdings in Encompass Health were worth $286,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in the business. UMB Bank n.a. lifted its position in Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after acquiring an additional 252 shares in the last quarter. V Square Quantitative Management LLC lifted its stake in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after purchasing an additional 140 shares during the last quarter. Oakworth Capital Inc. acquired a new position in Encompass Health in the second quarter valued at approximately $40,000. Benjamin F. Edwards & Company Inc. lifted its stake in Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after buying an additional 198 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Encompass Health during the second quarter valued at $58,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. UBS Group boosted their target price on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Royal Bank of Canada increased their price objective on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Truist Financial restated a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Stephens reissued an “overweight” rating and issued a $105.00 price target on shares of Encompass Health in a research note on Tuesday, August 6th. Finally, Barclays lifted their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $107.11.

Encompass Health Stock Performance

NYSE:EHC opened at $101.14 on Friday. The company has a 50-day moving average of $97.11 and a 200-day moving average of $90.81. The firm has a market cap of $10.19 billion, a price-to-earnings ratio of 24.43, a price-to-earnings-growth ratio of 1.31 and a beta of 0.88. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a twelve month low of $63.78 and a twelve month high of $104.55.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period last year, the firm posted $0.86 earnings per share. Analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.